MANGALAM SEEDS (539275)

Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• P/E of 14.16 is moderate, not overly stretched for a small-cap.
• ROE of 13.74% and ROCE of 12.19% suggest acceptable capital efficiency.
• Sales growth of 5.52% shows some underlying demand traction.
• Book value of ₹68.26 provides tangible asset backing, though the market price is far above it.

Concerns

• Profit growth is -5.19%, and the latest quarter shows only ₹1 Cr net profit on ₹29 Cr sales, implying very thin margins.
• Piotroski F-Score of 4/9 flags weak financial and operational health.
• P/B of 4.21 and PEG of 2.57 offer little margin of safety after the stock ran from ₹102.50 to ₹287.45.
• Zero dividend yield means no cash return while earnings are declining; promoter holding data is also absent.

AI Analysis

Let me look at Mangalam Seeds through the lens I have always used: what do I own, how durable is it, and what am I paying for it? This is a small agricultural seeds company with a market cap of ₹316 Cr, so liquidity and depth are limited. The latest quarter shows just ₹1 Cr of net profit on ₹29 Cr of sales—thin margins. The trailing P/E of 14.16 seems reasonable, but that is a trap if earnings are shrinking. Sales grew 5.52%, while profit fell 5.19%; that tells me pricing power is weak or costs are rising. The return on equity is 13.74%, decent, but the Piotroski F-Score of 4 out of 9 is a red flag for financial quality. Book value is ₹68.26, and at ₹287.45 the stock trades at 4.21 times book. For a business with falling profits and no dividend, that is not a margin of safety. The dividend yield is zero, so all returns depend on price appreciation. A PEG of 2.57 suggests the market is paying up for growth that has not shown up in numbers. The stock is at its 52-week high, having climbed from ₹102.50; such moves often reflect hope, not intrinsic value. I cannot evaluate promoter ownership because the data is unavailable, and I avoid depending on mystery. This has some characteristics of a decent small company—ROE above 13% and positive sales—but the recent deterioration and expensive valuation fail Graham's test. I would need a lower price, evidence that profit can recover, and a stronger balance-sheet signal before investing. In the meantime, I watch from the sidelines. Good businesses are common; good prices are not.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer